The WNT signalling pathway and diabetes mellitus

Area of Science:

• Molecular Biology
• Endocrinology
• Genetics

Background:

• The WNT signaling pathway regulates crucial physiological and pathophysiological processes.
• Key components include Frizzled receptors, co-receptors like LDL receptor-related protein 5/6 (LRP5/6), and the beta-catenin/T cell transcription factor (beta-cat/TCF) complex.
• This pathway is implicated in lipid metabolism, glucose homeostasis, and incretin hormone production.

Purpose of the Study:

• To explore the role of the WNT signaling pathway in the context of metabolic diseases, particularly type 2 diabetes.
• To investigate the genetic links between WNT pathway components, such as TCF7L2, and diabetes susceptibility.
• To understand how interactions between beta-catenin and FOXO proteins influence WNT activity and contribute to age-dependent diseases like type 2 diabetes.

Main Methods:

• Review of existing literature on WNT signaling, lipid/glucose metabolism, and diabetes genetics.
• Analysis of genome-wide association studies (GWAS) identifying TCF7L2 as a diabetes susceptibility gene.
• Examination of molecular interactions between beta-catenin and FOXO transcription factors.

Main Results:

• Mutations in LRP5 are associated with diabetes and obesity.
• TCF7L2 polymorphisms increase susceptibility to type 2 diabetes.
• Competition between FOXO and TCF proteins for beta-catenin can attenuate WNT signaling, particularly during aging and oxidative stress.

Conclusions:

• The WNT pathway is a significant factor in the pathogenesis of type 2 diabetes.
• Genetic variations in TCF7L2 highlight the pathway's importance in diabetes risk.
• Age-related changes in FOXO activity may contribute to the development of type 2 diabetes, offering new insights into its etiology.